physical dependence
pharmacologyA bodily adaptation to a substance such that stopping or reducing it produces a withdrawal syndrome; distinct from addiction and possible even with appropriate medical use.
Physical dependence is a physiological state in which the body has adapted to the continuous presence of a substance, such that reducing the dose or stopping entirely triggers a withdrawal — a cluster of symptoms that reflect the body readjusting to the substance's absence.
It is not the same as addiction. Physical dependence is a predictable biological consequence of regular exposure and can develop in anyone taking certain substances over time, including patients following a prescribed regimen. Addiction involves compulsive use and psychological craving; the two can co-occur but are distinct phenomena.
How it works · its role
When a substance repeatedly activates or suppresses a receptor system, the body compensates — a process called neuroadaptation. Receptors may be downregulated (reduced in number or sensitivity) in response to overstimulation, or upregulated in response to prolonged suppression.
While the substance is present, these adaptations are hidden; they maintain baseline function. When the substance is removed, the compensatory changes are unmasked. The nervous system is now running without its counterweight, and the result is a rebound effect in the opposing direction — the withdrawal syndrome.
The severity and character of withdrawal are largely determined by which receptor system was adapted. The longer the exposure and the higher the dose, the more pronounced the adaptation tends to be.
Relevance to substances & effects
Physical dependence is most clinically significant with substance classes that strongly modulate inhibitory or excitatory neurotransmission. Opioids produce dependence through μ-opioid adaptation; withdrawal involves a noradrenergic rebound that drives anxiety, muscle pain, and autonomic symptoms.
Benzodiazepines and alcohol both enhance GABA activity. With chronic use, the GABAergic system downregulates and the glutamatergic system compensates upward; stopping removes the suppression while the excitatory rebound remains, which can be severe.
SSRIs produce a milder form sometimes called discontinuation syndrome rather than withdrawal, reflecting a briefer recalibration of serotonin signalling. Beta-blockers and corticosteroids can also produce physical dependence through different mechanisms, illustrating that the phenomenon is not confined to psychoactive substances or drugs of misuse.
Tolerance & dependence
Physical dependence and tolerance often develop in parallel, since both reflect neuroadaptation to sustained exposure. Tolerance means a given dose produces a diminished effect over time; dependence means the absence of that dose produces symptoms. They are related processes but not identical — tolerance can develop without clinically meaningful dependence, and vice versa.
Recovery from physical dependence typically requires a gradual taper rather than abrupt cessation, allowing the adapted receptor systems time to recalibrate. The timeline varies considerably by substance class and duration of use — days to weeks for opioids, weeks to months for benzodiazepines used long-term.
Clinical · risk note
Withdrawal from alcohol and benzodiazepines carries genuine medical risk. Because both substances suppress central nervous system excitability, stopping them abruptly after heavy or prolonged use can precipitate seizures or, in severe cases, delirium — conditions requiring medical supervision.
Opioid withdrawal, while intensely uncomfortable, is rarely life-threatening in otherwise healthy adults, though it can be dangerous in people with underlying cardiovascular conditions or in neonates born to people who used opioids during pregnancy.
For any substance where physical dependence is likely, gradual dose reduction under medical guidance is preferable to abrupt discontinuation.
AI-generated · not yet verified by a human reviewer
Harm-reduction reference — not medical advice.